-
Multinational Study Highlights COVID-19 Vaccine Safety in MS
08 Jul 2025 22:14 GMT
… for individuals with multiple sclerosis (MS), especially … as myocarditis, pericarditis, vaccine-induced thrombotic thrombocytopenia, … -2 vaccines and multiple sclerosis: an update. … 2. Multiple sclerosis and COVID-19. National Multiple Sclerosis Society. …
-
Multiple Sclerosis Clinical Trial Pipeline Shows Potential With Active Contributions From 60+ Key Companies Delveinsight
24 Jun 2025 17:19 GMT
… advances in multiple sclerosis treatment drugs @ Multiple Sclerosis Competitive Report Multiple Sclerosis Overview Multiple sclerosis is … Nucleome Therapeutics, Vaccinex Inc., among others. Multiple Sclerosis Market Multiple Sclerosis Market Insights, …
-
Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight
24 Jun 2025 17:00 GMT
… advances in multiple sclerosis treatment drugs @ Multiple Sclerosis Competitive Report Multiple Sclerosis Overview Multiple sclerosis is … Nucleome Therapeutics, Vaccinex Inc., among others. Multiple Sclerosis Market Multiple Sclerosis Market Insights, …
-
'Inverse' vaccines may hold key to challenge autoimmune diseases
30 Jun 2025 09:06 GMT
NEW YORK, June 30 (UPI) -- For the millions of Americans battling autoimmune disorders, new hope may be on the horizon in the form of reverse or inverse vaccines -- injections that target a specific part of the immune system. experts told UPI.
However, …
-
Is contamination on a Canadian Armed Forces base making employees sick?
08 Jul 2025 12:52 GMT
Erin Zimmerman, a 46-year-old mother, wife, artist, public servant and veteran, has called the small city of Moose Jaw, Sask., population 35,000, home for the last 25 years. She joined the Canadian Armed Forces in 2012 and since 2016 has been working as a …
-
Multiple Sclerosis Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
05 Jun 2025 02:05 GMT
(MENAFN- GetNews)
DelveInsight's, “Multiple sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the pipeline drug profiles, including …
-
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
30 May 2025 11:30 GMT
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 Consortium of …
-
Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis
30 May 2025 05:16 GMT
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new, 96-week data for fenebrutinib demonstrating that patients with relapsing multiple sclerosis (RMS) maintained no disability progression and low levels of disease …
-
Remyelination in Multiple Sclerosis: Progress and Pipeline Updates
29 May 2025 19:25 GMT
… scale trials. Ultimately, Vaccinex decided to stop … the Treatment of Multiple Sclerosis. News release. Pipeline … Authorisation for Lead Multiple Sclerosis Therapeutic Candidate PTD802. … Authorisation-for-Lead-Multiple-Sclerosis-Therapeutic-Candidate-PTD802
…
-
Vaccine Expert and Former CDC Advisory Committee Member on RFK Jr.’s Firings
17 Jun 2025 20:06 GMT
… specific pro- or anti-vaccine agenda,” and later promised … that was an anti-vaccine activist, science denialist and … aluminum adjuvants cause autism or multiple sclerosis or diabetes or asthma, … — like him — anti-vaccine activists, who are science denialists …
About
© 1995-2025